1. Home
  2. TULP vs QNME Comparison

TULP vs QNME Comparison

Compare TULP & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bloomia Holdings Inc. Common Stock

TULP

Bloomia Holdings Inc. Common Stock

SELL

Current Price

$2.31

Market Cap

12.0M

ML Signal

SELL

QNME

Quanome Technologies Inc. Common Stock

HOLD

Current Price

$0.24

Market Cap

10.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
TULP
QNME
Founded
1990
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Integrated Freight & Logistics
Sector
Consumer Staples
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
10.5M
IPO Year
2026
2024

Fundamental Metrics

Financial Performance
Metric
TULP
QNME
Price
$2.31
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.4K
★ 573.1K
Earning Date
11-12-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.83
EPS
N/A
★ N/A
Revenue
★ $18,800,000.00
$5,850,681.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 111.79
52 Week Low
$2.00
$0.24
52 Week High
$4.99
$1.40

Technical Indicators

Market Signals
Indicator
TULP
QNME
Relative Strength Index (RSI) 42.34 33.15
Support Level $2.00 N/A
Resistance Level $2.50 $0.43
Average True Range (ATR) 0.14 0.04
MACD 0.05 -0.01
Stochastic Oscillator 53.09 2.36

Price Performance

Historical Comparison
TULP
QNME

About TULP Bloomia Holdings Inc. Common Stock

Bloomia Holdings Inc is a specialty agricultural company focused on making and managing its ag investments in the U.S. and internationally. The Company is the majority owner of Bloomia, one of the largest producers of fresh-cut tulips in the United States.

About QNME Quanome Technologies Inc. Common Stock

Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.

Share on Social Networks: